DCGI

Bal Pharma launches BALflu (favipiravir) tablets in India

Read more

MSN Laboratories launches Posaconazole to treat mucormycosis

Read more

Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment

Read more

DRDO launches anti-COVID drug 2-DG

Read more

Virafin from Zydus Cadila priced at Rs 11,995 per dose

Read more

States must ensure special teams to prevent black marketing of drugs: Centre to SC

Read more

DCGI nod for anti-COVID 19 drug developed by DRDO

Read more

MSN Laboratories launches Favilow (Faripiravir) 800 mg tablets

Read more

Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19

Read more

Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir

Read more